This data are linked to the publication "4D perfusion CT of prostate cancer for image-guided radiotherapy planning: a proof of concept study" published in Plos One.
The median PFS for patients in the IFI and ENI groups was 11 months and 13 months, respectively; the 1-, 2-, and 3-year PFS rates for patients between the IFI and ENI groups were 43.8%, 23.6%, and 21.